A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major | Haematologica

Yesim Aydinok; Zulal Ulger; Deniz Nart; Aysen Terzi; Nurten Cetiner; Gareth Ellis

首页> 外文期刊>Haematologica >A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major | Haematologica

【24h】

A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major | Haematologica

机译：重度地中海贫血患者每日一次去铁酮加每日两次去铁胺与每日一次去铁酮单药治疗的随机对照1年研究血液学

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and Objectives The aim of this prospective, randomized, 1-year study was to compare the efficacy and safety of oral deferiprone (DFP) with those of combinations of parenteral desferrioxamine (DFO) with oral DFP.

机译：背景与目的这项前瞻性，随机，为期1年的研究的目的是比较口服去铁酮（DFP）与肠胃外去铁胺（DFO）联合口服DFP的疗效和安全性。

著录项

来源
《Haematologica》 |2007年第12期|共8页
作者
Yesim Aydinok; Zulal Ulger; Deniz Nart; Aysen Terzi; Nurten Cetiner; Gareth Ellis;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients. [J] . Pantalone GR, Maggio A, Vitrano A, Hemoglobin: International Journal for Hemoglobin Research . 2011,第3期

机译：与去铁酮单药治疗相比，序贯交替使用去铁酮和去铁胺治疗：重型地中海贫血患者的大型多中心随机临床试验的主要发现和临床随访。
2. Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone | Haematologica [J] . Paul T. Telfer, Fiona Warburton, Soteroula Christou, Haematologica . 2009,第12期

机译：从去铁胺改为结合去铁胺和去铁酮的螯合治疗可改善地中海贫血主要患者的生存率血液学
3. Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone | Haematologica [J] . Paul T. Telfer, Fiona Warburton, Soteroula Christou, Haematologica . 2009,第12期

机译：从去铁胺改为结合去铁胺和去铁酮的螯合治疗可改善地中海贫血主要患者的生存率血液学
4. Using fuzzy logic for improving clinical daily-care of β-thalassemia patients [C] . S. Santini, A. Pescapé, A. S. Valente, IEEE International Conference on Fuzzy Systems . 2017

机译：使用模糊逻辑改善β地中海贫血患者的临床日常护理
5. Abdominal support and functional outcomes in patients undergoing major abdominal surgery: A randomized control trial. [D] . Cheifetz, Oren. 2006

机译：进行大腹部手术的患者的腹部支持和功能结局：一项随机对照试验。
6. Randomized clinical trial comparing the efficacy and safety of treatment with the once‐weekly dipeptidyl peptidase‐4 (DPP‐4) inhibitor omarigliptin or the once‐daily DPP‐4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy [O] . Ronald Goldenberg, Ira Gantz, Paula J. Andryuk, -1

机译：在二甲双胍单药治疗不能充分控制的2型糖尿病患者中比较每周两次使用二肽基肽酶-4（DPP-4）抑制剂奥格列汀或每天一次DPP-4抑制剂西他列汀治疗的有效性和安全性的随机临床试验
7. A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major [O] . Aydinok, Yesim, Ulger, Zulal, Nart, Deniz, 2007

机译：重型地中海贫血患者每日1次去铁酮加每日2次去铁胺与每日2次去铁酮单药治疗的随机对照1年研究

A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major | Haematologica

摘要

著录项

相似文献

相关主题

期刊订阅